Association of Treatment at High-Volume Facilities With Survival in Patients Receiving Chemoradiotherapy for Nasopharyngeal Cancer

Vivek Verma; Pamela K Allen; Charles B Simone 2nd; Hiram A Gay; Steven H Lin

doi:10.1001/jamaoto.2017.1874

Association of Treatment at High-Volume Facilities With Survival in Patients Receiving Chemoradiotherapy for Nasopharyngeal Cancer

JAMA Otolaryngol Head Neck Surg. 2018 Jan 1;144(1):86-89. doi: 10.1001/jamaoto.2017.1874.

Authors

Vivek Verma¹, Pamela K Allen², Charles B Simone 2nd³, Hiram A Gay⁴, Steven H Lin²

Affiliations

¹ Department of Radiation Oncology, University of Nebraska Medical Center, Omaha.
² Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
³ Department of Radiation Oncology, University of Maryland Medical Center, Baltimore.
⁴ Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.

Abstract

Using the National Cancer Database, this study examines the association of treatment at high-volume facilities with survival in patients receiving chemotherapy for nasopharyngeal cancer.